NASDAQ · Medical - Diagnostics & Research

Fulgent Genetics, Inc. (FLGT) Stock

$21.74 +4.42% NASDAQ: FLGT Healthcare

Valuation

MetricValue
Price$21.74
Market Cap$617.43M
P/E Ratio-7.62
P/B Ratio0.60
P/S Ratio1.88
EPS (TTM)$-1.97
52-Week High$31.04
52-Week Low$13.46
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-7.87%
ROA-7.75%
ROCE-11.80%
Gross Margin-28.17%
Operating Margin-28.17%
Net Margin-26.05%
Debt/Equity0.01
Current Ratio6.47

Annual Financials (USD)

Metric20212022202320242025
Revenue$993.0M$619.0M$289.0M$283.0M$323.0M
Operating Profit$676.0M$179.0M$-196.0M$-74.0M$-91.0M
Net Profit$507.0M$143.0M$-168.0M$-43.0M$-61.0M
EPS$16.26$4.63$-5.63$-1.41$-1.97
Op Margin68.1%28.8%-67.6%-26.1%-28.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.3B$1.4B$1.2B$1.2B$1.2B
Total Liabilities$113.0M$116.0M$102.0M$91.0M$107.0M
Cash$165.0M$80.0M$97.0M$55.0M$50.0M
Borrowings$21.0M$39.0M$15.0M$8.0M$8.0M

Latest News

Fulgent to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026 Business Wire · Jul 9, 2026 Fulgent Genetics (FLGT) Stock Faces Mixed Analyst Target Changes After Margin Questions Simply Wall St. · Jun 25, 2026 How The Fulgent Genetics (FLGT) Investment Story Is Evolving With Recent Developments Simply Wall St. · Jun 7, 2026 Fulgent Presents Updated FID-007 Data at ASCO 2026 Business Wire · Jun 1, 2026 Fulgent Genetics Inc (FLGT) Q1 2026 Earnings Call Highlights: Navigating Challenges with ... GuruFocus.com · May 2, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$539.0M$254.0M$27.0M$21.0M$-102.0M
Investing Cash Flow$-570.0M$-280.0M$17.0M$-99.0M$89.0M
Financing Cash Flow$-4.0M$-76.0M$-28.0M$-3.0M$-14.0M
Net Cash Flow$77.0M$-85.0M$18.0M$-42.0M$-5.0M
Free Cash Flow$515.0M$235.0M$5.0M$-19.0M$-124.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.13
EV / EBITDA-9.12
FCF Yield-17.01%
Quick Ratio6.18
Interest Coverage-504.67
Return 1Y5.83%
Return 3Y-50.01%
Return 5Y-73.30%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BLLNBillionToOne, Inc. $98.09 +2.81% 154.24 $4.51B 0.00%
FRNMFreenome, Inc. $15.78 -0.19% — $128.72M 0.00%
GHGuardant Health, Inc. $167.47 +1.15% -48.23 $22.47B 0.00%
MYGNMyriad Genetics, Inc. $4.31 +2.62% -3.80 $407.07M 0.00%
NEONeoGenomics, Inc. $16.35 +2.06% -9.31 $420.11M 0.00%

About Fulgent Genetics, Inc.

Fulgent Genetics, Inc. is led by CEO Ming Hsieh, employs 1,313 people, headquartered in US, publicly traded since 2016.

Fulgent Genetics, Inc. (FLGT) stock trades at $21.74 with a market capitalization of $617.43M. The stock is valued at a price-to-earnings (P/E) ratio of -7.62, price-to-book of 0.60, price-to-sales of 1.88. Over the past 52 weeks the stock has ranged between $13.46 and $31.04, and currently trades 30.0% below its 52-week high.

On profitability, Fulgent Genetics, Inc. generates a return on equity (ROE) of -7.87%, return on capital employed of -11.80%, an operating margin of -28.17%, a net profit margin of -26.05%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides